Today: 21 May 2026
Palantir stock drifts in early trade as tariff ruling looms and rate bets shift (PLTR)
9 January 2026
1 min read

Palantir stock drifts in early trade as tariff ruling looms and rate bets shift (PLTR)

NEW YORK, Jan 9, 2026, 09:35 ET — Regular session

Palantir Technologies Inc. shares were down 0.2% at $176.54 in early trade on Friday, giving back a small part of Thursday’s drop as investors sized up fresh U.S. labor data and a looming Supreme Court decision on tariffs.

The lack of a clean direction matters because Palantir has turned into a crowded wager on artificial intelligence spending, and those trades can swing on tiny changes in rates, policy and risk appetite.

It also lands at an awkward time for growth stocks. Investors want falling rates, but they also want enough economic momentum to keep big-ticket software projects alive. That mix has been unstable all week.

Global markets firmed after data showed U.S. payroll growth undershot expectations, a report that can tilt bets on Federal Reserve cuts. Reuters also reported the U.S. Supreme Court may rule later on Friday on the legality of President Donald Trump’s tariffs.

Palantir has traded more like a high-beta tech name than a defense contractor lately, and Thursday’s tape didn’t help. Chipmaker Nvidia and other megacaps weighed on the Nasdaq, while aerospace and defense shares rose to record highs after Trump advocated a $1.5 trillion military budget for 2027, Reuters reported.

For Palantir, the next hard checkpoint is whether it can deliver on targets it set in November. The company said it expected fourth-quarter revenue of $1.327 billion to $1.331 billion and adjusted income from operations of $695 million to $699 million, after third-quarter revenue rose 63% to $1.181 billion.

The stock ended Thursday at $176.82, down 2.68% from the prior session, according to a Yahoo Finance report. That leaves little cushion if the market’s mood turns again on policy headlines.

But the risks run both ways. If hiring and growth keep cooling, investors may lean harder into rate-cut hopes — and just as quickly start asking whether corporate software budgets are about to tighten.

Traders’ next market-moving marker is the Supreme Court tariff decision later on Friday. Beyond that, investors are watching for a confirmed date for Palantir’s next earnings report; Wall Street Horizon lists Feb. 2 after the close as “unconfirmed.”

Stock Market Today

  • Analysts Boost Broadcom Price Targets Despite Stock Dip
    May 20, 2026, 11:22 PM EDT. Broadcom (AVGO) shares fell 6.5% to $411.07 on May 19, retreating from a record high of $439.79 on May 14. Despite this drop, several major analysts raised their price targets. Wells Fargo lifted its target to $545 from $430, TD Cowen to $500 from $405, and UBS to $490 from $475, all maintaining buy ratings. Evercore ISI's Mark Lipacis, a top-ranked analyst, raised his target to $582, citing growing demand for Broadcom's custom AI chips amid shifts in AI workloads. Risks remain from semiconductor market volatility and geopolitical tensions impacting chip deals. Broadcom's strategic moves, including its VMware acquisition and partnerships with Google and Meta for AI-focused chips, position it well in enterprise infrastructure and AI growth.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Ondas stock jumps again in premarket after SEC resale filing, with insider sale notice in the mix
Previous Story

Ondas stock jumps again in premarket after SEC resale filing, with insider sale notice in the mix

Sensex, Nifty slump for fifth day — what’s spooking India’s stock market right now
Next Story

Sensex, Nifty slump for fifth day — what’s spooking India’s stock market right now

Go toTop